Association of mannose-binding-lectin deficiency with severe atherosclerosis

Lancet

Volumn 352, Issue 9132, 1998, Pages 959-960

  Madsen, Hans O ^b   Videm, Vibeke ^b   Svejgaard, Arne ^b   Svennevig, Jan L ^b   Garred, Peter ^a  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; MANNOSE BINDING PROTEIN;

ARTICLE; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032547573     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61513-9     Document Type: Article

References (5)

1. 1 Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-36.
2. 2 Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-40.
3. 3 Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding protein alleles in patients with suspected immunodeficiency. Lancet 1995; 346: 941-43.
4. 4 Swanson A, Ezekowitz RAB, Lee A, Kuo C-C. Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immunol 1998; 66: 1607-12.
5. 5 Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A. Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 1994; 21: 125-31.